Our Pipeline

Vita aims to be a global leader in cell engineering through successful completion of clinical trials for its pipeline of programs leveraging platforms in both neuromuscular and immunotherapy.

Clinical Trials

Vita Therapeutics will soon be recruiting 15 patients for a first-in-human (FIH) clinical trial of VTA-100. Please monitor this site for more details on the trial and timing.